FI
AMAM

Fosun International’s Ambrx Biopharma Inc AMAM Stock Holding History

Fosun International’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-249,190
Closed -$2.22M – 62
2023
Q1 		$2.22M Sell
249,190
-1,683,401
-87% -$8.46M 0.21% 29
2022
Q4 		$4.39M Hold
1,932,591
– – 0.36% 27
2022
Q3 		$2.09M Hold
1,932,591
– – 0.22% 42
2022
Q2 		$5.12M Hold
1,932,591
– – 0.71% 32
2022
Q1 		$7.96M Hold
1,932,591
– – 0.69% 32
2021
Q4 		$17.5M Hold
1,932,591
– – 1% 13
2021
Q3 		$26.1M Hold
1,932,591
– – 1.34% 14
2021
Q2 		$37.9M Buy
+1,932,591
New +$32.9M 2.25% 8

Other funds holding AMAM

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.3B AUM 42.97% 1-Year Est. Return